Clinical trial
Rapid Motion-Robust Quantitative DCE-MRI For The Assessment Of Gynecologic Cancer
NCT04893434 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Motion-Robust Quantitative DCE-MRI For The Assessment Of Gynecologic Cancer
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- May 13, 2021
- Completion date
- May 31, 2027
- Enrollment
- 24 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
gynecologic cancer